Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0111
+0.0106 (2,120.00%)
At close: Oct 26, 2026
Trevena Market Cap
Trevena has a market cap or net worth of $10.64 thousand as of November 10, 2026. It is the 51,858th most valuable company in the world and the 7,794th biggest in the United States. Its market cap has decreased by 7.49% in one year.
Market Cap
10.64K
Enterprise Value
n/a
Revenue
546.00K
Global Rank
Country Rank
#7,794 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 10.64K, a decrease of -99.99%. That is a compound annual growth rate of -53.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 10.64K | -7.49% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 16.17K |
| Statera Biopharma | 14.52K |
| Vaxxinity | 12.68K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Carisma Therapeutics | 8.37K |